• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

TSUDA Naotake  津田 尚武

ORCIDConnect your ORCID iD *help
… Alternative Names

津田 尚武  ツダ ナオタケ

Less
Researcher Number 60341351
Other IDs
Affiliation (Current) 2025: 久留米大学, 医学部, 教授
Affiliation (based on the past Project Information) *help 2007 – 2013: Kurume University, 医学部, 助教
Review Section/Research Field
Principal Investigator
Obstetrics and gynecology
Keywords
Principal Investigator
卵巣癌 / microRNA / 子宮体癌 / 上皮間葉転換 / 癌幹細胞 / 婦人科腫瘍学 / 癌ワクチン / RNA
  • Research Projects

    (2 results)
  • Research Products

    (8 results)
  •  the development of synthetic microRNA to cancer stem cell of gynecological cancerPrincipal Investigator

    • Principal Investigator
      TSUDA Naotake
    • Project Period (FY)
      2011 – 2013
    • Research Category
      Grant-in-Aid for Young Scientists (B)
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Kurume University
  •  The development of the polysomal RNA vaccine to the ovarian cancerPrincipal Investigator

    • Principal Investigator
      TSUDA Naotake
    • Project Period (FY)
      2007 – 2010
    • Research Category
      Grant-in-Aid for Young Scientists (B)
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Kurume University

All 2009 2008

All Journal Article

  • [Journal Article] N-terminally LRMK-linked HER-2 peptides, AE-37 [p776(774-788)] and AE-47 [Ava-F7(776-788)], aid differentiation of E75-TCR+CD8+ cells to perforin-positive cells.2009

    • Author(s)
      Matsueda S, Gao H, Efferson CL, Tsuda N, Ishiyama S, Li Y, Ioannides MG, Fisk B, Peoples GE, Ioannides CG
    • Journal Title

      Anticancer Research 29(7)

      Pages: 2427-2435

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-19791178
  • [Journal Article] Distinct patient responses to activation of T-cells by free HER-2, G89 (777-789) and protected LRMK-linked HER-2, {AE-39 [p776 (Ava-774-788)], AE-47 [(Ava-776-788)] and AE-37[p776 (774-788)]} peptides could lead to development of personalized cancer vaccines2009

    • Author(s)
      Li Y, Matsueda S, Efferson CL, Tsuda N, Kawano K, Gao H, Peoples GE, Ioannides CG.
    • Journal Title

      Anticancer Research 29(1)

      Pages: 41-58

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-19791178
  • [Journal Article] Distinct patient responses to activation of T-cells by free HER-2, G89 (777-789) and protected LRMK-linked HER-2, {AE-39 [p776 (Ava-774-788)], AE-47 [(Ava-776-788)] and AE-37[p776 (774-788)]} peptides could lead to development of personalized cancer vaccines.2009

    • Author(s)
      Li Y, Matsueda S, Efferson CL, Tsuda N, Kawano K, Gao H, Peoples GE, Ioannides CG.
    • Journal Title

      Anticancer Res. 29(1)

      Pages: 41-58

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-19791178
  • [Journal Article] Synthetic microRNA targeting glioma-associated antigen-1 protein.2009

    • Author(s)
      Tsuda N, Mine T, Ioannides CG, Chang DZ.
    • Journal Title

      Methods Mol Biol. 487

      Pages: 435-449

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-19791178
  • [Journal Article] Expression of activated signal transducer and activator of transcription-3 predicts poor prognosis in cervical squamous-cell carcinoma.2009

    • Author(s)
      Takemoto S, Ushijima K, Kawano K, Yamaguchi T, Terada A, Fujiyoshi N, Nishio S, Tsuda N, Ijichi M, Kakuma T, Kage M, Hori D, Kamura T.
    • Journal Title

      Br J Cancer. 101(6)

      Pages: 967-972

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-19791178
  • [Journal Article] HER-2 peptides p776 and F7, N-terminal-linked with Ii-Key tetramer (LRMK) help the proliferation of E75-TCR+ cells : The dependency of help on the side chains of LRMK-extended peptide pointed towards the T cell receptor2008

    • Author(s)
      Li Y, Ishiyama S, Matsueda S, Tsuda N, Ioannides CG
    • Journal Title

      Oncol Rep 19(6)

      Pages: 1445-1452

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-19791178
  • [Journal Article] HER-2 peptides p776 and F7, N-terminal-linked with Ii-Key tetramer (LRMK) help the proliferation of E75-TCR+ cells: The dependency of help on the side chains of LRMK-extended peptide pointed towards the T cell receptor2008

    • Author(s)
      Li Y, Ishiyama S, Matsueda S, Tsuda N, Ioannides CG
    • Journal Title

      Oncol Rep 9(6)

      Pages: 1445-52

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-19791178
  • [Journal Article] Cap43/NDRG1/Drg-1 is a molecular target for angiogenesis and a prognostic indicator in cervical adenocarcinoma.2008

    • Author(s)
      Nishio S, Ushijima K, Tsuda N, Takemoto S, Kawano K, Yamaguchi T, Nishida N, Kakuma T, Tsuda H, Kasamatsu T, Sasajima Y, Kage M, Kuwano M, Kamura T.
    • Journal Title

      Cancer Lett. 264(1)

      Pages: 36-43

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-19791178

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi